Use of cetuximab as an adjuvant agent to radiotherapy and surgery in recessive dystrophic epidermolysis bullosa with squamous cell carcinoma

Citation

• Kim, M., Li, M., Intong, L. R. A., Tran, K., Melbourne, W., Marucci, D., . . . Murrell, D. F. (2013). Use of cetuximab as an adjuvant agent to radiotherapy and surgery in recessive dystrophic epidermolysis bullosa with squamous cell carcinoma. British Journal of Dermatology, 169(1), 208-210. doi:10.1111/bjd.12272

Digital Object Identifier (doi)

• 10.1111/bjd.12272

Scopus Eid

• 2-s2.0-84879906192

Web Of Science Accession Number

Start Page

• 208

End Page

• 210

Volume

• 169

Issue

• 1

Abstract

UOW Authors

•   De Souza, Paul (external author)

Publication Date

• 2013

Publisher

• Wiley 

Published In

• British Journal of Dermatology  Journal

Citation

• Kim, M., Li, M., Intong, L. R. A., Tran, K., Melbourne, W., Marucci, D., . . . Murrell, D. F. (2013). Use of cetuximab as an adjuvant agent to radiotherapy and surgery in recessive dystrophic epidermolysis bullosa with squamous cell carcinoma. British Journal of Dermatology, 169(1), 208-210. doi:10.1111/bjd.12272

Digital Object Identifier (doi)

• 10.1111/bjd.12272

Scopus Eid

• 2-s2.0-84879906192

Web Of Science Accession Number

Start Page

• 208

End Page

• 210

Volume

• 169

Issue

• 1